Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals.
D000368:Aged; D001815:Bloodletting; D003300:Copper / Q000097:blood; D003676:Deferoxamine / Q000627:therapeutic use; D006410:Hematopoiesis; D006801:Humans; D007501:Iron / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008111:Liver Function Tests; D008274:Magnesium / Q000097:blood; D008875:Middle Aged; D011164:Porphyrias / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D011166:Porphyrins / Q000652:urine; D012806:Siderosis / Q000209:etiology; D012877:Skin Manifestations; D014131:Trace Elements / Q000378:metabolism*; D015032:Zinc / Q000097:blood
D011166:Porphyrins; D014131:Trace Elements; D003300:Copper; D007501:Iron; D008274:Magnesium; D003676:Deferoxamine; D015032:Zinc